Advertisement

Topics

Latest "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Stories

04:17 EDT 2nd May 2016 | BioPortfolio

Here are the most relevant search results for "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" found in our extensive news archives from over 250 global news sources.

More Information about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine for you to read. Along with our medical data and news we also list autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Clinical Trials, which are updated daily. BioPortfolio also has a large database of autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Companies for you to search.

Showing "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Articles 1–25 of 14,000+

Extremely Relevant

Prolonged Cell Division Arrest Prevents Development of Cancers Caused by Epstein-Barr Virus

A mechanism has been identified that helps explain why despite most people having been infected with Epstein-Barr virus, very few...


Atara Bio Receives EMA Orphan Drug Designation for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes to Treat Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder

SOUTH SAN FRANCISCO, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation, today announced that the European Medicines Agency (EMA) granted orphan drug designation for the Company’s allogeneic ...

Donor epstein-barr serostatus influences GVHD after allo-HSCT

(HealthDay)—Donor Epstein-Barr virus (EBV) serostatus influences incidence of graft-versus-host disease (GVHD) in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT), according to a study published online April 18 in the Journal of Clinical Oncology.


Enzyme Proves Viable Drug Target for Epstein-Barr Virus Infections in Duncan's Disease Patients

For certain genetic disorders, an infection can trigger an overly aggressive immune response that does more harm than good to the patient. New research suggests that targeting a single enzyme could put the brakes on a lethal immune response triggered by Epstein-Barr virus (EBV) in patients with X-linked lymphoproliferative disease (XLP-1). The

Grand Challenge two: wipe out cancers caused by the Epstein-Barr Virus

We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus.

Disrupting cell's supply chain freezes cancer virus

(Duke University) The cancer-causing Epstein-Barr virus tricks B-Cells of the human immune system into rapid cell division. To satisfy demand for more building parts, host cells will chew up their insides to free up more amino acids, fats and nucleotides. The virus also switches the cell's source of fuel to keep division going. A Duke team finds that cutting off the supply chain puts the cell in a...

LYMPHOME associé au virus d'Epstein-Barr: Une nouvelle immunothérapie adoptive - UdeM

Eduquer le système immunitaire pour qu'il devienne capable de reconnaitre des maladies spécifiques et de les combattre. C'est le principe de ce projet clinique en essai de phase I visant à traiter des lymphomes associés au virus EBV (virus d'Epstein-Barr) par le biais d'une immunothérapie adoptive cellulaire spécifique contre le virus. Son objectif, redonn...

Immunotherapy for Epstein-Barr related lymphomas

(University of Montreal) Health Canada recently approved, for the first time in Canada, a clinical project for a Phase I study aimed at treating lymphomas associated with the Epstein-Barr virus through adoptive cellular immunotherapy that is specific to EBV. By adapting methods initially developed in the US, the project is designed to help restore the ability of immune-compromised patients to figh...

BRIEF-Atara biotherapeutics says European Medicines Agency granted orphan drug designation for allogeneic epstein-barr virus targeted cytotoxic t-lymphocyte product candidate

* European Medicines Agency granted orphan drug designation for allogeneic epstein-barr virus targeted cytotoxic t-lymphocyte product candidate

Atara Bio Receives FDA Orphan Drug Designation for EBV-CTL to Treat Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder (EBV-PTLD)

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the Compa...

Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns

Medical News Today: Drug shows promise for halting cancer virus

Scientists have discovered they can use the drug rapamycin to freeze the advance of cancer-causing Epstein-Barr virus in cells by putting the cells into a dormant state.

[Articles] Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

This is the first study providing evidence for Zika virus infection causing Guillain-Barré syndrome. Because Zika virus is spreading rapidly across the Americas, at risk countries need to prepare for adequate intensive care beds capacity to manage patients with Guillain-Barré syndrome.

Study shows that certain herpes viruses can infect human neurons

For years, researchers have noted a tantalizing link between some neurologic conditions and certain species of the herpes virus. In patients with Alzheimer's disease, multiple sclerosis, and cerebellar ataxia, among other neuropathies, the cerebrospinal fluid teems with Epstein-Barr virus (EBV). Yet, the nature of that link has remained unclear, as it has been assumed that EBV, as well as other vi...

Certain herpes viruses can infect human neurons

(University of Pennsylvania School of Medicine) A tantalizing link exists between some neurologic conditions and certain species of herpes virus. In some patients with Alzheimer's disease, multiple sclerosis, and cerebellar ataxia, among others, the cerebrospinal fluid teems with Epstein-Barr virus. Yet, the link remains unclear. It's been assumed that EBV, and viruses in the same family cannot in...

Zika virus might cause Guillain-Barré syndrome, according to new evidence

Analysis of blood samples from 42 patients diagnosed with Guillain-Barré syndrome (GBS) during the Zika virus outbreak in French Polynesia provides the first evidence that Zika virus might cause GBS, a severe neurological disorder, according to new research. Based on the analysis of data from French Polynesia, if 100,000 people were infected with Zika virus, 24 would develop GBS.

[Comment] Zika virus: time to move from case reports to case control

Until the French Polynesian outbreak in 2013–14, Zika virus disease was thought to be only a mild disease. During this outbreak, the incidence of Guillain-Barré syndrome was 20 times higher than expected.1 Similarly, the emergence of Zika virus in the Americas since 2015 has been associated with a dramatic increase of reported cases of microcephaly.2 As for Zika virus and Guillain-Barré syndro...

Novel Epstein-Barr Virus Vaccines

Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis and is associated with certain types of cancers, such as Hodgkin's lymphoma, Burkitt's lymphoma, gastric carcinoma, and nasopharyngeal carcinoma. There are currently no vaccines against EBV on the market and there is only supportive treatment available for EBV infection. The subject technologies are novel vaccine candidat...

Heart Failure Drug Could Treat Herpes Virus, Suggest Study

Early research suggests the heart failure drug spironolactone hinders infection from the Epstein-Barr virus, a pathogen linked to mono and different types of cancer. Spironolactone is a “potassium-sparing diuretic” that prevents potassium levels from dropping too low and ensures the body doesn’t absorb excess levels of salt. Congestive heart failure patients also take the drug to treat flui...

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines

Heart Failure Drug Could Treat Herpes Virus, Suggests Study

Early research suggests the heart failure drug spironolactone hinders infection from the Epstein-Barr virus, a pathogen linked to mono and different types of cancer. Spironolactone is a “potassium-sparing diuretic” that prevents potassium levels from dropping too low and ensures the body doesn’t absorb excess levels of salt. Congestive heart failure patients also take the drug to treat flui...

LabRoots to Host DiaSorin Webinar That Fills in Common Knowledge Gaps About Epstein-Barr Virus Infection

The Webinar will discuss clinical findings and lab tests for diagnosing and staging primary EBV infection, mechanisms by which it causes cancer and autoimmune diseases, and research aimed at preventing it, May 17, 2016 Yorba Linda, CA (PRWEB) April 25, 2016 Despite the fact that infectious mononucleosis has been known as a unique disease for more than 100 years, and that Epstein-Barr virus—whic...

Researchers confirm causal link between Zika virus and Guillain-Barré Syndrome

French researchers suspect that Zika Virus is responsible for the cause of Guillain-Barré Syndrome (GBS), a severe form of limb paralysis that is often accompanied by respiratory impairment requiring intensive care.

Explainer: what is Guillain-Barré syndrome and is it caused by the Zika virus?

Steven Maltby, University of Newcastle The recent outbreak of Zika virus in South America has been a cause of concern. This is not because Zika itself is a serious condition, but because it is believed to be linked to birth defects when expectant mothers are infected and to a rare but severe and progressive neurological […] The post Explainer: what is Guillain-Barré syndrome and is it cause...

Origins of the Zika outbreak and its potential threat

Researchers are working to understand more about the Zika virus — how it is transmitted, its link to microcephaly and Guillain-Barré syndrome and whether a vaccine can be developed.


Quick Search
Advertisement
 

News Quicklinks